{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:23:00Z","timestamp":1793496180267,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["10094"],"award-info":[{"award-number":["10094"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Programme","award":["647047"],"award-info":[{"award-number":["647047"]}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1136\/ijgc-2020-001776","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T05:20:44Z","timestamp":1614576044000},"page":"314-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Management of pregnancy in women with cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"Vera","family":"Wolters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0550-2793","authenticated-orcid":false,"given":"Joosje","family":"Heimovaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Maggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyce","family":"Cardonick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Boere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Lenaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001776_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.2008.17.4110","article-title":"Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study","volume":"27","author":"Stensheim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0015","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1373\/clinchem.2019.306548","article-title":"Noninvasive prenatal testing and detection of occult maternal malignancies","volume":"65","author":"Lenaerts","year":"2019","journal-title":"Clin Chem"},{"key":"10.1136\/ijgc-2020-001776_bb0020","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/AOG.0b013e3182a057a2","article-title":"Incidence of pregnancy-associated cancer in Denmark, 1977-2006","volume":"122","author":"Eibye","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001776_bb0025","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1508913","article-title":"Pediatric outcome after maternal cancer diagnosed during pregnancy","volume":"373","author":"Amant","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001776_bb0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1470-2045(18)30059-7","article-title":"Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients","volume":"19","author":"de Haan","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0035","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1080\/14767058.2018.1536117","article-title":"Impact of cancer in the management of delivery: 10 years of variations","volume":"33","author":"Masturzo","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1136\/ijgc-2020-001776_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2020.07.004","article-title":"Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy","volume":"138","author":"Vandenbroucke","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2020-001776_bb0045","first-page":"1","article-title":"Biological effects after prenatal irradiation (embryo and fetus)","volume":"33","author":"Valentin","year":"2003","journal-title":"Ann ICRP"},{"key":"10.1136\/ijgc-2020-001776_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1470-2045(05)70169-8","article-title":"Radiotherapy during pregnancy: fact and fiction","volume":"6","author":"Kal","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/0955300031000114729","article-title":"Risk coefficients for childhood cancer after intrauterine irradiation: a review","volume":"79","author":"Wakeford","year":"2003","journal-title":"Int J Radiat Biol"},{"key":"10.1136\/ijgc-2020-001776_bb0060","author":"American College of Radiology","year":"2020","journal-title":"ACR manual on contrast media. Version 2020"},{"key":"10.1136\/ijgc-2020-001776_bb0065","author":"American College of Radiology","year":"2018","journal-title":"ACR-SPR practice parameter for imaging pregnant or potentially pregnant adolescents and women with ionizing radiation. Resolution 39"},{"key":"10.1136\/ijgc-2020-001776_bb0070","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s00330-017-5126-z","article-title":"Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study","volume":"28","author":"Han","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1136\/ijgc-2020-001776_bb0075","article-title":"Efficacy of oral contrast agents for upper gastrointestinal signal suppression in MRCP: a systematic review of the literature","volume":"6","author":"Frisch","year":"2017","journal-title":"Acta Radiol Open"},{"key":"10.1136\/ijgc-2020-001776_bb0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10549-017-4611-z","article-title":"Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy","volume":"168","author":"Han","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1136\/ijgc-2020-001776_bb0085","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1096-9926(199904)59:4<236::AID-TERA9>3.0.CO;2-6","article-title":"Administered radionuclides in pregnancy","volume":"59","author":"Adelstein","year":"1999","journal-title":"Teratology"},{"key":"10.1136\/ijgc-2020-001776_bb0090","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/IGC.0000000000000752","article-title":"Utility of laparoscopic indocyanine green-guided sentinel node biopsy in open cervical cancer surgery","volume":"26","author":"Rychlik","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001776_bb0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.reprotox.2016.04.017","article-title":"Maternal-fetal transfer of indocyanine green across the perfused human placenta","volume":"62","author":"Rubinchik-Stern","year":"2016","journal-title":"Reprod Toxicol"},{"key":"10.1136\/ijgc-2020-001776_bb0100","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.suronc.2010.10.002","article-title":"Anaphylactic response to blue dye during sentinel lymph node biopsy","volume":"20","author":"B\u00e9zu","year":"2011","journal-title":"Surg Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0105","doi-asserted-by":"crossref","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","article-title":"Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24(Suppl 6)","author":"Peccatori","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0110","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/annonc\/mdz228","article-title":"Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting","volume":"30","author":"Amant","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.09.036","article-title":"Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial","volume":"222","author":"Obermair","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001776_bb0120","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ygyno.2010.08.019","article-title":"Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model","volume":"119","author":"Van Calsteren","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0125","first-page":"1456","article-title":"Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model","volume":"20","author":"Calsteren","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001776_bb0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","article-title":"Use of chemotherapy during human pregnancy","volume":"5","author":"Cardonick","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ctrv.2015.03.001","article-title":"Targeted agents for cancer treatment during pregnancy","volume":"41","author":"Lambertini","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1136\/ijgc-2020-001776_bb0140","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.2015.62.4445","article-title":"Hematologic malignancies in pregnancy: management guidelines from an international consensus meeting","volume":"34","author":"Lishner","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10549-012-1996-6","article-title":"Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01)","volume":"133","author":"Azim","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1136\/ijgc-2020-001776_bb0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/bdrb.21176","article-title":"An evaluation of the impact of PD-1 pathway blockade on reproductive safety of therapeutic PD-1 inhibitors","volume":"107","author":"Poulet","year":"2016","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1136\/ijgc-2020-001776_bb0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.seminoncol.2018.03.003","article-title":"Viable pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy","volume":"45","author":"Burotto","year":"2018","journal-title":"Semin Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0160","first-page":"1","article-title":"Case report of a pregnancy during ipilimumab therapy","volume":"4","author":"Mehta","year":"2018","journal-title":"J Glob Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0165","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes","volume":"368","author":"Pasternak","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001776_bb0170","author":"Briggs","year":"2011"},{"key":"10.1136\/ijgc-2020-001776_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4236\/jct.2012.32021","article-title":"The use of Neupogen (filgrastim) or Neulasta (pegfilgrastim) during pregnancy when chemotherapy is indicated for maternal cancer treatment","volume":"03","author":"Cardonick","year":"2012","journal-title":"J Cancer Ther"},{"key":"10.1136\/ijgc-2020-001776_bb0180","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/gim.2016.113","article-title":"Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies","volume":"19","author":"Brison","year":"2017","journal-title":"Genet Med"},{"key":"10.1136\/ijgc-2020-001776_bb0185","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamaoncol.2015.1883","article-title":"Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing","volume":"1","author":"Amant","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0190","article-title":"[Incidental detection of maternal malignancy in non-invasive prenatal test]","volume":"163","author":"Saes","year":"2019","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1136\/ijgc-2020-001776_bb0195","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/pd.5544","article-title":"Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing","volume":"39","author":"Lenaerts","year":"2019","journal-title":"Prenat Diagn"},{"key":"10.1136\/ijgc-2020-001776_bb0200","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.13190","article-title":"Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)","volume":"42","author":"Lees","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001776_bb0205","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1471-0528.2012.03475.x","article-title":"Incidence and outcomes of pregnancy-associated cancer in Australia, 1994-2008: a population-based linkage study","volume":"119","author":"Lee","year":"2012","journal-title":"BJOG"},{"key":"10.1136\/ijgc-2020-001776_bb0210","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1200\/JCO.1987.5.7.1098","article-title":"Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents","volume":"5","author":"Reynoso","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/COC.0000000000000527","article-title":"Incidence of neonatal neutropenia and leukopenia after in utero exposure to chemotherapy for maternal cancer","volume":"42","author":"La Nasa","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0220","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-3-540-71274-9_16","article-title":"Metastatic involvement of placenta and foetus in pregnant women with cancer","volume":"178","author":"Pavlidis","year":"2008","journal-title":"Recent Results Cancer Res"},{"key":"10.1136\/ijgc-2020-001776_bb0225","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1200\/JCO.2003.12.149","article-title":"Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant","volume":"21","author":"Alexander","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0230","doi-asserted-by":"crossref","first-page":"S745","DOI":"10.1016\/j.ajog.2017.11.577","article-title":"Pathophysiology of placental-derived fetal growth restriction","volume":"218","author":"Burton","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001776_bb0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.placenta.2018.03.002","article-title":"Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restriction","volume":"64","author":"Verheecke","year":"2018","journal-title":"Placenta"},{"key":"10.1136\/ijgc-2020-001776_bb0240","author":"World Health Organization","year":"2012","journal-title":"Resolution WHA65.6. Comprehensive implementation plan on maternal, infant and young child nutrition"},{"key":"10.1136\/ijgc-2020-001776_bb0245","first-page":"165","article-title":"Administration of cyclophosphamide during late pregnancy and early lactation: a case report","volume":"71","author":"Durodola","year":"1979","journal-title":"J Natl Med Assoc"},{"key":"10.1136\/ijgc-2020-001776_bb0250","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0890334412459374","article-title":"Transfer of carboplatin and paclitaxel into breast milk","volume":"28","author":"Griffin","year":"2012","journal-title":"J Hum Lact"},{"key":"10.1136\/ijgc-2020-001776_bb0255","article-title":"Integrated network-diversity analyses suggest suppressive effect of Hodgkin's lymphoma and slightly relieving effect of chemotherapy on human milk microbiome","volume":"6","author":"Ma","year":"2016","journal-title":"Sci Rep"},{"key":"10.1136\/ijgc-2020-001776_bb0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/bfm.2016.0166","article-title":"After chemotherapy treatment for maternal cancer during pregnancy, is breastfeeding possible?","volume":"12","author":"Stopenski","year":"2017","journal-title":"Breastfeed Med"},{"key":"10.1136\/ijgc-2020-001776_bb0265","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/bfm.2020.29157.hmj","article-title":"ABM Clinical Protocol #34: breast cancer and breastfeeding","volume":"15","author":"Academy of Breastfeeding Medicine","year":"2020","journal-title":"Breastfeed Med"},{"key":"10.1136\/ijgc-2020-001776_bb0270","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM199103213241205","article-title":"Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood","volume":"324","author":"Lipshultz","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001776_bb0275","first-page":"635","author":"Resnik","year":"2009"},{"key":"10.1136\/ijgc-2020-001776_bb0280","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(11)70363-1","article-title":"Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study","volume":"13","author":"Amant","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0285","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1469-0705.1995.05060400.x","article-title":"Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization","volume":"5","author":"Mari","year":"1995","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001776_bb0290","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S1470-2045(12)70261-9","article-title":"Treatment of breast cancer during pregnancy: an observational study","volume":"13","author":"Loibl","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-001776_bb0295","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2352-3026(19)30195-4","article-title":"Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study","volume":"6","author":"Maggen","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1136\/ijgc-2020-001776_bb0300","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ijgc-2018-000061","article-title":"Management of cancer during pregnancy and current evidence of obstetric, neonatal and pediatric outcome: a review article","volume":"29","author":"Maggen","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001776_bb0305","doi-asserted-by":"crossref","first-page":"658.e1","DOI":"10.1016\/j.ajog.2014.11.032","article-title":"Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls","volume":"212","author":"Cardonick","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001776_bb0310","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3816\/CLM.2001.n.023","article-title":"Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero","volume":"2","author":"Avil\u00e9s","year":"2001","journal-title":"Clin Lymphoma"},{"key":"10.1136\/ijgc-2020-001776_bb0315","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/ijgc-2019-000416","article-title":"Effects of in-utero exposure to chemotherapy on fetal brain growth","volume":"29","author":"Passera","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001776_bb0320","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/pbc.24138","article-title":"Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients","volume":"59","author":"Yancey","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1136\/ijgc-2020-001776_bb0325","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/AOG.0000000000000389","article-title":"A child with severe hearing loss associated with maternal cisplatin treatment during pregnancy","volume":"124","author":"Geijteman","year":"2014","journal-title":"Obstet Gynecol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24020176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24020176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:38:24Z","timestamp":1753223904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24020176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1048891X24020176"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001776","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of pregnancy in women with cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https:\/\/creativecommons.org\/licenses\/by\/4.0\/.","name":"copyright","label":"Copyright"}]}}